<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(13)</volume><submitter>Islam MA</submitter><funding>University of Dhaka</funding><pubmed_abstract>Surface-functionalized Mg&lt;sub>1-&lt;i>x&lt;/i>&lt;/sub> Co &lt;sub>&lt;i>x&lt;/i>&lt;/sub> Fe&lt;sub>2&lt;/sub>O&lt;sub>4&lt;/sub> (0 ≤ &lt;i>x&lt;/i> ≤ 1; Δ&lt;i>x&lt;/i> = 0.1) can be an exciting candidate as an MRI contrast agent and for thermotherapeutic applications. The figure-of-merit, &lt;i>T&lt;/i> &lt;sub>2&lt;/sub>, relaxivity, &lt;i>r&lt;/i> &lt;sub>2&lt;/sub>, of MRI and specific loss power, SLP, of hyperthermia depend on the structural and magnetic properties of the nanoparticles. We synthesized cobalt-substituted magnesium ferrite Mg&lt;sub>1-&lt;i>x&lt;/i>&lt;/sub> Co &lt;sub>&lt;i>x&lt;/i>&lt;/sub> Fe&lt;sub>2&lt;/sub>O&lt;sub>4&lt;/sub> (0 ≤ &lt;i>x&lt;/i> ≤ 1 with Δ&lt;i>x&lt;/i> = 0.1) nanoparticles using a chemical co-precipitation method. The lattice parameter and average crystallite size increase with the increase in cobalt content. The force-constant of FTIR of the tetrahedral sit</pubmed_abstract><journal>RSC advances</journal><pagination>7835-7849</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8982169</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Efficacy of surface-functionalized Mg&lt;sub>1-&lt;i>x&lt;/i>&lt;/sub> Co &lt;sub>&lt;i>x&lt;/i>&lt;/sub> Fe&lt;sub>2&lt;/sub>O&lt;sub>4&lt;/sub> (0 ≤ &lt;i>x&lt;/i> ≤ 1; Δ&lt;i>x&lt;/i> = 0.1) for hyperthermia and &lt;i>in vivo&lt;/i> MR imaging as a contrast agent.</pubmed_title><pmcid>PMC8982169</pmcid><pubmed_authors>Islam MA</pubmed_authors><pubmed_authors>Syed IM</pubmed_authors><pubmed_authors>Rashid R</pubmed_authors><pubmed_authors>Hasan MR</pubmed_authors><pubmed_authors>Haque MM</pubmed_authors><pubmed_authors>Hoque SM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Efficacy of surface-functionalized Mg&lt;sub>1-&lt;i>x&lt;/i>&lt;/sub> Co &lt;sub>&lt;i>x&lt;/i>&lt;/sub> Fe&lt;sub>2&lt;/sub>O&lt;sub>4&lt;/sub> (0 ≤ &lt;i>x&lt;/i> ≤ 1; Δ&lt;i>x&lt;/i> = 0.1) for hyperthermia and &lt;i>in vivo&lt;/i> MR imaging as a contrast agent.</name><description>Surface-functionalized Mg&lt;sub>1-&lt;i>x&lt;/i>&lt;/sub> Co &lt;sub>&lt;i>x&lt;/i>&lt;/sub> Fe&lt;sub>2&lt;/sub>O&lt;sub>4&lt;/sub> (0 ≤ &lt;i>x&lt;/i> ≤ 1; Δ&lt;i>x&lt;/i> = 0.1) can be an exciting candidate as an MRI contrast agent and for thermotherapeutic applications. The figure-of-merit, &lt;i>T&lt;/i> &lt;sub>2&lt;/sub>, relaxivity, &lt;i>r&lt;/i> &lt;sub>2&lt;/sub>, of MRI and specific loss power, SLP, of hyperthermia depend on the structural and magnetic properties of the nanoparticles. We synthesized cobalt-substituted magnesium ferrite Mg&lt;sub>1-&lt;i>x&lt;/i>&lt;/sub> Co &lt;sub>&lt;i>x&lt;/i>&lt;/sub> Fe&lt;sub>2&lt;/sub>O&lt;sub>4&lt;/sub> (0 ≤ &lt;i>x&lt;/i> ≤ 1 with Δ&lt;i>x&lt;/i> = 0.1) nanoparticles using a chemical co-precipitation method. The lattice parameter and average crystallite size increase with the increase in cobalt content. The force-constant of FTIR of the tetrahedral sit</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-06-01T01:31:05.177Z</modification><creation>2025-06-01T01:31:05.177Z</creation></dates><accession>S-EPMC8982169</accession><cross_references><pubmed>35424744</pubmed><doi>10.1039/d2ra00768a</doi></cross_references></HashMap>